Clover Health also announced an initial research partnership and license agreement with Genentech, a biotechnology company which discovered the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Ex-Pfizer exec Cheng Zhang will lead Clover Therapeutics; Endpoint news is reporting that...
